Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Johnson

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
European Journal of Heart Failure|August 8, 2024
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of CardiologyKaren Sliwa, Amina Rakisheva, Charle Viljoen, et al.
International Journal of Cardiology|November 18, 2023
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registryKaren Sliwa, Peter van der Meer, Charle Viljoen, et al.
The Lancet. Respiratory Medicine|December 17, 2022
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure|June 11, 2021
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM RegistryAlice M Jackson, Mark C Petrie, Alexandra Frogoudaki, et al.
European Heart Journal|August 26, 2020
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Mark C Petrie, Peter van der Meer, et al.
Heart (British Cardiac Society)|September 20, 2019
Maternal and neonatal outcomes in women with history of coronary artery diseaseMatthew Cauldwell, Philip J Steer, Katherine von Klemperer, et al.
European Journal of Heart Failure|February 20, 2021
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyKaren Sliwa, Peter van der Meer, Mark C Petrie, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
European Journal of Heart Failure|August 8, 2024
Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of CardiologyKaren Sliwa, Amina Rakisheva, Charle Viljoen, et al.
International Journal of Cardiology|November 18, 2023
Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registryKaren Sliwa, Peter van der Meer, Charle Viljoen, et al.
The Lancet. Respiratory Medicine|December 17, 2022
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure|June 11, 2021
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM RegistryAlice M Jackson, Mark C Petrie, Alexandra Frogoudaki, et al.
European Heart Journal|August 26, 2020
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryKaren Sliwa, Mark C Petrie, Peter van der Meer, et al.
Heart (British Cardiac Society)|September 20, 2019
Maternal and neonatal outcomes in women with history of coronary artery diseaseMatthew Cauldwell, Philip J Steer, Katherine von Klemperer, et al.
European Journal of Heart Failure|February 20, 2021
Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyKaren Sliwa, Peter van der Meer, Mark C Petrie, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Pageof 21